Delivery Order SPE2DR25D3005-SPE2DR26FP8WC
- Not listed
- The Defense Logistics Agency awarded a $2,496.87 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.12 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (18-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The awardee is a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $2,696.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 count). This is a non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,233.95 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (8 count) on January 16, 2026, with completion scheduled for January 20, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,092.44 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count package) on December 10, 2025, with completion expected by December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,803.36 delivery order on December 30, 2025, for Yuvafem 10 mcg vaginal inserts (18 units). This is a firm fixed-price, non-set-aside contract with a completion date of December 31, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.27 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.49 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count package) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8WCDelivery Order
The Defense Logistics Agency awarded a $7,739.54 delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (8-count). This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 26, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems including the military and veterans' programs. AmerisourceBergen holds a significant $999,999,999 IDC with DLA Troop Support Medical through December 2026, which serves as the primary contracting vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally. This delivery order represents one of many task orders fulfilling the company's role as a critical pharmaceutical vendor supporting the Defense Health Agency and other federal medical institutions. The parent company, Cencora, Inc., also maintains a comparable $999,999,999 IDC with DLA extending through December 2031, demonstrating the company's ongoing importance to federal medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 1/22/26 |